TM9SF1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 9.34790023165988E-11 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
4.03660000000139E-05 |
Normal-vs-Stage2 |
1.67200000511514E-08 |
Normal-vs-Stage3 |
6.88116230662672E-13 |
Normal-vs-Stage4 |
5.50000001098283E-09 |
Stage1-vs-Stage2 |
2.340000E-03 |
Stage1-vs-Stage3 |
7.65979999983735E-07 |
Stage1-vs-Stage4 |
1.438730E-03 |
Stage2-vs-Stage3 |
6.234200E-01 |
Stage2-vs-Stage4 |
8.728400E-01 |
Stage3-vs-Stage4 |
7.686000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
6.62909727111582E-11 |
Normal-vs-AfricanAmerican |
1.984640E-04 |
Normal-vs-Asian |
1.879540E-02 |
Caucasian-vs-AfricanAmerican |
2.896600E-01 |
Caucasian-vs-Asian |
9.115200E-01 |
AfricanAmerican-vs-Asian |
7.580400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
3.50575124485886E-12 |
Normal-vs-Female |
1.78689999996706E-06 |
Male-vs-Female |
6.084700E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
7.84310000000454E-05 |
Normal-vs-Age(41-60Yrs) |
5.79899994690436E-09 |
Normal-vs-Age(61-80Yrs) |
6.58569976330625E-10 |
Normal-vs-Age(81-100Yrs) |
1.328470E-02 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.434800E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.280600E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.056000E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.880400E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.378200E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.569200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
4.586200E-01 |
Normal-vs-Grade 2 |
3.16540000000476E-06 |
Normal-vs-Grade 3 |
5.76459990853095E-11 |
Normal-vs-Grade 4 |
1.92389992825781E-10 |
Grade 1-vs-Grade 2 |
4.319200E-03 |
Grade 1-vs-Grade 3 |
1.239740E-04 |
Grade 1-vs-Grade 4 |
1.196470E-04 |
Grade 2-vs-Grade 3 |
2.099900E-03 |
Grade 2-vs-Grade 4 |
1.588840E-04 |
Grade 3-vs-Grade 4 |
1.086570E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.7459399999975E-05 |
Normal-vs-ccB subtype |
1.91213711531191E-12 |
ccA subtype-vs-ccB subtype |
1.63710000000705E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
3.95389998519846E-09 |
Normal-vs-N1 |
3.21930004876236E-09 |
N0-vs-N1 |
1.004470E-02 |
|
|